Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Thanks Go horns, larscot, sge1.....Awaiting further input, additions corrections

So in order to do that, the BOD needs to move forward on buybacks agressively put the shares to treasury and NOT do any reverses...correct?

 

Only if they can buy back over 300,000,000 shares, if not, a reverse must be a serious consideration. How realistic is a valuation of over $2bn($5 @ current o/s)to move onto another exchange?

 

 

Be well

Share
New Message
Please login to post a reply